The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation
Iranian Journal of Blood and Cancer · 01.12.2022 · 14 (4) · 84-94
DOI: 10.58209/ijbc.14.4.84 ↗Kurz gefasst
Fachartikel in der Zeitschrift Iranian Journal of Blood and Cancer, online erschienen am 01.12.2022. Verfasst von Seyed H. Ghaffari und 13 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ghaffari, S. H., Osfouri, E., Ahmadvand, M., Bashash, D., Ghaffari, P., Niavarani, A., Hossaini, E., Yaghmaie, M., Koohi, R., Ghashgha, A. I., Pourbagheri-Sigaroodi, A., Mousavi, S. A., Alimoghaddam, K., & Ghavamzadeh, A. (2022). The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation. Iranian Journal of Blood and Cancer, 14(4), 84-94. https://doi.org/10.58209/ijbc.14.4.84
Vancouver
Ghaffari SH, Osfouri E, Ahmadvand M, Bashash D, Ghaffari P, Niavarani A, et al. The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation. Iranian Journal of Blood and Cancer. 2022;14(4):84-94. doi:10.58209/ijbc.14.4.84
BibTeX
@article{Ghaffari2022,
author = {Ghaffari, Seyed H. and Osfouri, Ebrahim and Ahmadvand, Mohammad and Bashash, Davood and Ghaffari, Parisa and Niavarani, Ahmadreza and Hossaini, Elham and Yaghmaie, Marjan and Koohi, Roghieh and Ghashgha, Andisheh ie and Pourbagheri-Sigaroodi, Atieh and Mousavi, Seyed A. and Alimoghaddam, Kamran and Ghavamzadeh, Ardeshir},
title = {The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation},
journal = {Iranian Journal of Blood and Cancer},
year = {2022},
volume = {14},
number = {4},
pages = {84--94},
doi = {10.58209/ijbc.14.4.84}
}
EUVIMED